Akari Therapeutics, Plc (AKTX)
NASDAQ·Healthcare·Biotechnology
$5.72
+2.14%
Mkt Cap $4.49K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$30.00
Range $30.00 – $30.00
Implied Upside
+424.5%
Consensus $30.00 vs current $5.72
NASDAQ·Healthcare·Biotechnology
$5.72
+2.14%
Mkt Cap $4.49K
No recent rating data.
Price Target (1 analysts)
$30.00
Range $30.00 – $30.00
+424.5%
Consensus $30.00 vs current $5.72